CLYM
Climb Bio
CLYM
CLYM
64 hedge funds and large institutions have $157M invested in Climb Bio in 2025 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 21 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
20.02% less ownership
Funds ownership: 65.78% → 45.76% (-20%)
Holders
64
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$6.42M | |
| 2 | +$3.35M | |
| 3 | +$3.12M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$2.35M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.72M |
Top Sellers
| 1 | -$48.3M | |
| 2 | -$2.01M | |
| 3 | -$1.1M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$1.02M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$976K |
